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Over the last two decades, there have been vast improvements in sepsis-related outcomes, largely resulting from
the widespread adoption of aggressive fluid resuscitation and infection control. With increased understanding of
the pathophysiology of sepsis, novel diagnostics and resuscitative interventions are being discovered. In recent years,
few diagnostic tests like lactate have engendered more attention and research in the sepsis arena. Studies highlighting
lactate’s prognostic potential for mortality and other outcomes are ubiquitous and largely focus on the early stage of
sepsis management, defined as the initial 6 h and widely referred to as the “golden hours.” Additional investigations,
although more representative of surgical and trauma patients, suggest that lactate measurements beyond 24 h
from the initiation of resuscitation continue to have predictive and prognostic utility. This review summarizes the
current research and evidence regarding lactate’s utility as a prognosticator of clinical outcomes in both early and
late sepsis management, defines the mechanism of lactate production and clearance, and identifies areas warranting
further research.
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Nearly a decade since the landmark article, “Surviving
Sepsis Campaign Guidelines for Management of Severe
Sepsis and Septic Shock,” sepsis remains a hotbed of re-
search, and new diagnostic and resuscitative interven-
tions are under continual development and evaluation.
One such effort that has received focus is the role of
lactate monitoring and whether measurements taken
on initial presentation and serially can be used as tar-
gets of clinical end points including adequate resuscita-
tion and in-hospital mortality [1–6].Review
Mechanism of hyperlactemia in sepsis and septic shock
Traditionally, lactic acidosis in sepsis is attributed to
anaerobic glycolysis due to inadequate oxygen delivery.
However, it has become clear that the mechanism of
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James et al. proposed that lactic acidosis refractory to
standard resuscitation is frequently due to increased
aerobic glycolysis in skeletal muscle secondary to
epinephrine-stimulated Na+, K+-ATPase activity and
not to anaerobic glycolysis from hypoperfusion, and
warned that continued attempts at resuscitation target-
ing lactate levels could lead to unnecessary blood trans-
fusion and use of inotropic agents [8]. Furthermore,
Gutierrez et al. emphasized that the etiology of pro-
longed lactic acidosis in sepsis is often multifactorial,
making it an unreliable marker of oxygen debt and in-
adequate resuscitation [7]. Interestingly, it has been
demonstrated that septic patients with hyperlactemia
after 24 h of resuscitation had similar lactate produc-
tion but lower lactate clearance than septic patients
with normal blood lactate [9]. This finding raises
doubts about the reliability of hyperlactemia as an indi-
cator of the intensity of anaerobic metabolism in septic
patients, suggesting instead that persistence of hyper-
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overproduction [9].
These findings questioned the notion that hyperlacte-
mia in sepsis and septic shock is solely the result of hy-
poperfusion. Further support for the role of inadequate
lactate clearance stems from Gibot et al. who used an
endotoxemia model to demonstrate that lactate levels
in sepsis can be elevated despite adequate systemic per-
fusion, blood pressure, and oxygen delivery [10]. Simi-
larly, in a pig model, Ven Genderen et al. showed that
septic shock behaves differently from obstructive/circu-
latory shock that even when cardiac output and other
systemic parameters are optimized, there continues to
be regional microvascular oxygen mismatch in septic
shock, as compared to obstructive/circulatory shock.
The authors postulate that this regional microvascular
oxygen mismatch leads to elevations in lactate that may
be partially unresponsive to traditional resuscitative in-
terventions that only target systemic parameters [11].
Likewise, Hernandez et al. showed lactate in septic
shock to have a biphasic response, with an initial rapid
improvement followed by a much slower normalization
many hours later, and hypothesized that this slow and
delayed response might be attributed to the micro-
vascular oxygen mismatch as described by Ven Genderen
et al., making further systemic resuscitation through
traditional sepsis resuscitation bundles ineffective and
perhaps detrimental [12]. In fact, Marik et al. attribute
hyperlactemia in the later phase of sepsis to increased
aerobic glycolysis due to a stress response and also
label any attempts at using traditional sepsis therapies
to normalize lactate during this later stage as flawed
and potentially harmful [13]. With these findings, Rivers
et al. warn against using only lactate clearance as a marker
of sepsis recovery and state that lactate clearance,
central venous oxygen saturation (ScvO2), and other
markers are complementary and not mutually exclu-
sive end points [14].
Thus, new insight regarding the mechanism for hyper-
lactemia in sepsis following adequate initial resuscitation
and infection control demonstrates that tissue hypoxia is
not the sole etiology of hyperlactemia during late sepsis.
Nevertheless, data supporting the clinical utility of lac-
tate as a marker of early sepsis recovery is robust while
the role of continued lactate monitoring beyond the ini-
tial resuscitation period into the stage of late sepsis and
its potential to guide treatment during this later stage
remains uncertain [15–18].
Lactate as a prognosticator in early sepsis management
In their 2004 and 2008 sepsis guidelines, Dellinger et al.
recommended measurement of lactate on initial presen-
tation, with an elevated value signifying tissue hypoper-
fusion and necessitating aggressive resuscitation [19–21].Although their guidelines suggested measuring lactate
only upon presentation, many clinicians and researchers
have attempted to capitalize on the test’s theoretical
diagnostic and predictive value by including additional
measurements during the resuscitation process [22–26].
For example, it was shown that lactate clearance greater
than 10 % from initial measurement during the first 2 to
6 h of resuscitation predicted survival from septic shock
and that protocols targeting lactate clearance of at least
10 % produced similar short-term survival rates to proto-
cols using ScvO2 monitoring [2, 22, 23, 25]. Moreover, it
was demonstrated that for every 10 % increase in lactate
clearance, there was a corresponding 11 % decrease in in-
hospital mortality [2]. Similarly, septic patients with lactate
clearance of greater than 20 % during the initial 8 h of re-
suscitation had a 22 % decline in the relative risk of mor-
tality, compared with patients having lactate clearances of
less than 20 % [24].
Since these initial studies are evaluating lactate as a
marker of recovery in sepsis and septic shock, further
research has evaluated the role of lactate monitoring
during the early resuscitative period. For example,
Puskarich et al. studied resuscitation during the initial
6 h of treatment and demonstrated that achieving an
ScvO2 goal ≥70 % without obtaining a lactate clear-
ance goal ≥10 % was associated with higher mortality
than reaching the lactate clearance goal without the
ScvO2 goal [27]. Furthermore, these same authors
showed that early lactate normalization (within 6 h)
was a predictor of survival in patients being treated
for sepsis and septic shock [28]. Nguyen et al. investi-
gated the addition of lactate clearance within the first
12 h of resuscitation to the severe sepsis resuscitation
bundle and showed that including lactate clearance
leads to an almost twofold increase in relative risk re-
duction of death [29]. In response to the convincing
literature supporting the utility of lactate clearance in
early sepsis, the newest surviving sepsis guidelines for
early goal-directed therapy (EGDT) now includes lactate
clearance during the first 6 h of resuscitation as a goal of
early resuscitation [24]. Thus, research regarding lactate
monitoring as a marker of recovery in severe sepsis and
septic shock has proven fruitful but has primarily focused
on the early resuscitation period [23–28].
Lactate as a late prognosticator in sepsis management
Literature evaluating the clinical and predictive value of
lactate measurements beyond the initial 6-h resuscita-
tion period in the medical management of sepsis is sig-
nificantly less robust [30–34]. In a study of 137 surgical
intensive care unit (SICU) patients, Husain et al. showed
elevated initial and 24-h lactate levels to be significant
predictors of mortality, with mortality ranging from 10
to 67 % depending on whether lactate levels normalized
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other study investigating SICU patients, Bakker et al.
showed that lactate clearance measured 24 h after ad-
mission was a significant predictor of in-hospital mor-
tality and that the duration of persistent lactic acidosis
was more predictive of mortality than the initial lactate
value [30]. Similarly, Friedman et al. showed in a 35-
patient study that survivors of severe sepsis admitted to
the medical intensive care unit (MICU) or SICU had
significantly lower lactate values at 24 h of resuscitation
than nonsurvivors [31]. Finally, Manikis et al. followed
lactate measurements every 8 h for >72 h in 129 trauma
patients and demonstrated serial lactate measurements
and the duration of hyperlactemia to be reliable indicators
of morbidity and mortality following trauma [32–34]. In a
94-patient SICU sepsis study, Marty et al. measured lac-
tate at time0 (T),T6,T12, and T24 and showed that the best
predictor of death was the T24 clearance. These authors
concluded that during the first 24 h in the ICU, hyper-
lactemia, even after the “golden hours,” is associated
with increased mortality, and lactate clearance-directed
therapy should be considered for the first 24 h of treat-
ment [36]. Similarly, in an 81-patient study, Herwanto
et al. investigated the role of 6-, 12-, and 24-h lactate
clearance in patients with sepsis and septic shock and
found only the 24-h lactate clearance measurements to
be associated with mortality [37].
Rationale for further research
Monitoring serial lactate measurements during early
sepsis is a clinically useful tool as both a clinical end
point to target and for prognostication; however, the
utility of monitoring lactate beyond the initial 24 h of treat-
ment is a poorly studied topic in the current literature.
Although late sepsis is loosely defined in prior stud-
ies, it is characterized by microcirculatory dysfunction
leading to end organ failure and increased mortality
[11, 12, 15, 38, 39]. Interestingly, failure to achieve
lactate clearance beyond the golden hours despite micro-
circulatory restoration suggests that normalization of this
microcirculatory dysfunction likely requires therapeutic
interventions that differ from those used in early sepsis
management [38, 40, 41]. Moreover, after the initial
resuscitation has lead to restoration of microcircula-
tory parameters (i.e., cardiac output, ScvO2, mean ar-
terial pressure), further attempts at normalizing
lactate with traditional resuscitative techniques are likely
detrimental [11, 12, 15]. For these reasons, further re-
search evaluating the role of lactate kinetics during late
sepsis management has the potential to guide physicians
in their management of septic patients and improve clin-
ical outcomes. Should an association between poor lactate
kinetics and mortality exists during this later period, fur-
ther studies could then investigate interventions targetingthe microcirculatory impairment among septic patients
with abnormal lactate kinetics after the first 24 h of resus-
citation [38, 39].
Recently, the ProCESS, ARISE, and ProMISe trials
have provided convincing evidence that EGDT is not
superior to usual care in sepsis management [42–44].
With the foundational treatment paradigm for sepsis
now being called into question, it is crucial to investigate
the benefits of the individual components of sepsis man-
agement, both early and later in the course of care. Studies
attempting to elucidate the potential value of one particu-
lar sepsis prognostic indicator, specifically lactate, later
in the management of septic patients could prove benefi-
cial [45].
Conclusions
Extensive investigations into the efficacy of lactate kinet-
ics as a marker for response to resuscitative therapies in
septic patients have demonstrated a clear association
with clinical outcomes including mortality. However, the
majority of these studies have focused on the utility dur-
ing the early phase of sepsis management, with little
attention regarding later time periods. Future studies
focusing on lactate as a potential prognostic tool for late
sepsis management and treatment duration have the
potential to direct physicians in their care for septic
patients during this understudied time period and
improve patient outcomes.
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